Xi'an International Medical Investment Company (000516) Fair Value & Analysis
Healthcare · CN · Market cap 9.0B CNY
Fair value as of: Jul 21, 2026
From 11 valuation models · updated 20 days ago
Fair value updated Jul 21, 2026, revised from ¥0.9300 to ¥0.8300 (−10.8%) since Jun 25, 2026. Share price +8.7% over the past month.
A solid business, but screening 80% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case (¥1.35). The favourable scenario is already priced in.
- The model range is unusually wide (¥0.3100 to ¥1.35). The outcome hinges heavily on assumptions, so read the point estimate with caution.
- Solid but not exceptional quality (54/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 21, 2026.
How to read this chart
60‑month range ¥3.86 – ¥21.13 · fair‑value band ¥0.3100 – ¥1.35 · the ¥4.25 price screens above the ¥0.8300 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 21, 2026.
Analysis
Xi'an International Medical Investment Company (000516) currently trades at ¥4.25, while our model-based Fair Value estimate is ¥0.8300, implying the stock looks roughly 80.5% overvalued today. The Quality Score stands at 54/100 (solid quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, Xi'an International Medical Investment Company generated revenue of 4.0B CNY at a net margin of -6.3%. Revenue declined 2.8% year over year. It earns a return on equity of -11.5%. Net debt stands at 2.8B CNY. Fundamentals as of Jul 21, 2026
Our scenario range runs from ¥0.3100 (bear case) to ¥1.35 (bull case); at ¥4.25, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 31% below its 52-week high and 11% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 11% fair-value upside, at -80%, 000516 screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 11 models by family
Widest divergence: Growth DCF (¥3.38) versus Asset-Based (¥0.9900). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 21, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 54 · Market factors (momentum, volatility) 36
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Xi'an International Medical Investment Company Limited provides healthcare services. It operates hospitals and medical centers. It also engages in insurance broking, tourism, and pharmaceutical production business. Xi'an International Medical Investment Company Limited was formerly known as Xi'an Kaiyuan Investment Group Co., Ltd.
Full company description
Xi'an International Medical Investment Company Limited provides healthcare services. It operates hospitals and medical centers. It also engages in insurance broking, tourism, and pharmaceutical production business. Xi'an International Medical Investment Company Limited was formerly known as Xi'an Kaiyuan Investment Group Co., Ltd. and changed its name to Xi'an International Medical Investment Company Limited in January 2015. The company was founded in 1986 and is based in Xi'an, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Xi'an International Medical Investment Company reported revenue of ¥4.1B in FY2025 versus ¥2.9B in FY2021, a compound +8.7%/yr. Reported net income was −¥313M in FY2025.
000516 screens 80% overvalued. Compare with HCA Healthcare, Inc →
Peer Group
Medical Care Facilities · 262 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 21, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $378.85 | $554.93 | +46% |
| Fresenius SE FRE | €41.73 | €32.15 | -23% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.58 SGD | 1.44 SGD | -44% |
| Tenet Healthcare Corporation THC | $194.91 | $338.05 | +73% |
| Rede D'Or São Luiz S.A RDOR3 | R$36.01 | R$47.31 | +31% |
| DaVita Inc DVA | $231.61 | $255.97 | +11% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,955 | ₹2,955 | -67% |
| Fresenius Medical Care AG FMS | $24.68 | $45.60 | +85% |
| Aier Eye Hospital Group 300015 | ¥8.68 | ¥7.67 | -12% |
Compare Xi'an International Medical Investment Company with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Xi'an International Medical Investment Company (000516) overvalued or undervalued?
What is the fair value of 000516?
What is the quality score of 000516?
What is the revenue of Xi'an International Medical Investment Company (000516)?
What is the net profit margin of 000516?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Xi'an International Medical Investment Company and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.